The company says it will feature studies on vitamin K2, choline, folate, and MSM, along with beverage concepts and a first-time pet corner.
|Articles|February 7, 2012
Gelita AG Sells Shares in R.P. Scherer
Catalent Pharma is the buyer in the transaction.
Advertisement
Gelita AG (Eberbach, Germany) is selling its 49% of total shares in
Gelita says its stock in R.P. Scherer was purely a financial investment and does not reflact any tie to its corebusiness. Gelita will still supply R.P. Scherer with gelatin, energy, fresh water, and other resources.
The transaction must be approved by regulatory authorities before it is complete.
Advertisement
Related to this article
The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.
Kemin to Pair FloraGLO Lutein Milestone With Gut Health and Satiety Ingredients at SupplySide Global
The company says it will center on positive aging, with a focus on lutein research beyond vision, the Gutopia platform, and Slendesta for the GLP-1 market.
The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.
A look at the market data and functional ingredient innovations driving the next generation of nutrition bars.
NNB Nutrition says the finished product is the first to carry the certification using its creatine ingredient, which also holds Informed Choice certification and has undergone third-party impurity testing.
The proposed notification requirement is straightforward, but its legal and commercial consequences are not.
The company plans to unveil a clinically studied ingredient on opening day and host a longevity session alongside its cognitive, mobility, and metabolic health portfolio.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
CRN Survey Links FDA Supplement Listing to Higher Consumer Confidence
2
EFSA Outlines Scientific Priorities Ahead of Its 2027 Strategy
3
Kemin to Pair FloraGLO Lutein Milestone With Gut Health and Satiety Ingredients at SupplySide Global
4
Omega-3 Supply, Not Price, Is the Real Threat
5